Selected research
Industry Research
Buspirone Industry Research Report 2026
Market perspective
The global Buspirone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Buspirone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Buspirone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Buspirone include Teva, Novartis, Mylan, Wockhardt, Watson Laboratories, Orion Corporation, Laboratoires Servier, Hikma and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Buspirone market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Buspirone Market by Company
Teva
Novartis
Mylan
Wockhardt
Watson Laboratories
Orion Corporation
Laboratoires Servier
Hikma
Dr. Reddy's Laboratories
Cadila Healthcare
Bristol Myers Squibb
Apotex
AMAG Pharmaceuticals
Buspirone Segment by Type
10mg
15mg
30mg
5mg
Buspirone Segment by Application
Hospital
Drug Store
Buspirone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buspirone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Buspirone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buspirone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Buspirone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Buspirone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Buspirone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 15mg
- 30mg
- 5mg
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Novartis
- Mylan
- Wockhardt
- Watson Laboratories
- Orion Corporation
- Laboratoires Servier
- Hikma
- Dr. Reddy's Laboratories
- Cadila Healthcare
- Bristol Myers Squibb
- Apotex
- AMAG Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Buspirone Market Size (2021-2032)
- 2.2.2 Global Buspirone Sales (2021-2032)
- 2.2.3 Global Buspirone Market Average Price (2021-2032)
- 2.3 Buspirone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10mg
- 2.3.3 15mg
- 2.3.4 30mg
- 2.3.5 5mg
- 2.4 Buspirone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Buspirone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Buspirone Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Buspirone Revenue of Manufacturers (2021-2026)
- 3.4 Global Buspirone Average Price by Manufacturers (2021-2026)
- 3.5 Global Buspirone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Buspirone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Buspirone, Product Type & Application
- 3.8 Global Manufacturers of Buspirone, Established Date
- 3.9 Global Buspirone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Buspirone Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Buspirone Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Buspirone Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Wockhardt
- 4.4.1 Wockhardt Company Information
- 4.4.2 Wockhardt Business Overview
- 4.4.3 Wockhardt Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wockhardt Buspirone Product Portfolio
- 4.4.5 Wockhardt Recent Developments
- 4.5 Watson Laboratories
- 4.5.1 Watson Laboratories Company Information
- 4.5.2 Watson Laboratories Business Overview
- 4.5.3 Watson Laboratories Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Watson Laboratories Buspirone Product Portfolio
- 4.5.5 Watson Laboratories Recent Developments
- 4.6 Orion Corporation
- 4.6.1 Orion Corporation Company Information
- 4.6.2 Orion Corporation Business Overview
- 4.6.3 Orion Corporation Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Orion Corporation Buspirone Product Portfolio
- 4.6.5 Orion Corporation Recent Developments
- 4.7 Laboratoires Servier
- 4.7.1 Laboratoires Servier Company Information
- 4.7.2 Laboratoires Servier Business Overview
- 4.7.3 Laboratoires Servier Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Laboratoires Servier Buspirone Product Portfolio
- 4.7.5 Laboratoires Servier Recent Developments
- 4.8 Hikma
- 4.8.1 Hikma Company Information
- 4.8.2 Hikma Business Overview
- 4.8.3 Hikma Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hikma Buspirone Product Portfolio
- 4.8.5 Hikma Recent Developments
- 4.9 Dr. Reddy's Laboratories
- 4.9.1 Dr. Reddy's Laboratories Company Information
- 4.9.2 Dr. Reddy's Laboratories Business Overview
- 4.9.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr. Reddy's Laboratories Buspirone Product Portfolio
- 4.9.5 Dr. Reddy's Laboratories Recent Developments
- 4.10 Cadila Healthcare
- 4.10.1 Cadila Healthcare Company Information
- 4.10.2 Cadila Healthcare Business Overview
- 4.10.3 Cadila Healthcare Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cadila Healthcare Buspirone Product Portfolio
- 4.10.5 Cadila Healthcare Recent Developments
- 4.11 Bristol Myers Squibb
- 4.11.1 Bristol Myers Squibb Company Information
- 4.11.2 Bristol Myers Squibb Business Overview
- 4.11.3 Bristol Myers Squibb Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bristol Myers Squibb Buspirone Product Portfolio
- 4.11.5 Bristol Myers Squibb Recent Developments
- 4.12 Apotex
- 4.12.1 Apotex Company Information
- 4.12.2 Apotex Business Overview
- 4.12.3 Apotex Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Apotex Buspirone Product Portfolio
- 4.12.5 Apotex Recent Developments
- 4.13 AMAG Pharmaceuticals
- 4.13.1 AMAG Pharmaceuticals Company Information
- 4.13.2 AMAG Pharmaceuticals Business Overview
- 4.13.3 AMAG Pharmaceuticals Buspirone Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AMAG Pharmaceuticals Buspirone Product Portfolio
- 4.13.5 AMAG Pharmaceuticals Recent Developments
5 Global Buspirone Market Scenario by Region
- 5.1 Global Buspirone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Buspirone Sales by Region: 2021-2032
- 5.2.1 Global Buspirone Sales by Region: 2021-2026
- 5.2.2 Global Buspirone Sales by Region: 2027-2032
- 5.3 Global Buspirone Revenue by Region: 2021-2032
- 5.3.1 Global Buspirone Revenue by Region: 2021-2026
- 5.3.2 Global Buspirone Revenue by Region: 2027-2032
- 5.4 North America Buspirone Market Facts & Figures by Country
- 5.4.1 North America Buspirone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Buspirone Sales by Country (2021-2032)
- 5.4.3 North America Buspirone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Buspirone Market Facts & Figures by Country
- 5.5.1 Europe Buspirone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Buspirone Sales by Country (2021-2032)
- 5.5.3 Europe Buspirone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Buspirone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Buspirone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Buspirone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Buspirone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Buspirone Market Facts & Figures by Country
- 5.7.1 South America Buspirone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Buspirone Sales by Country (2021-2032)
- 5.7.3 South America Buspirone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Buspirone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Buspirone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Buspirone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Buspirone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Buspirone Sales by Type (2021-2032)
- 6.1.1 Global Buspirone Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Buspirone Sales Market Share by Type (2021-2032)
- 6.2 Global Buspirone Revenue by Type (2021-2032)
- 6.2.1 Global Buspirone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Buspirone Revenue Market Share by Type (2021-2032)
- 6.3 Global Buspirone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Buspirone Sales by Application (2021-2032)
- 7.1.1 Global Buspirone Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Buspirone Sales Market Share by Application (2021-2032)
- 7.2 Global Buspirone Revenue by Application (2021-2032)
- 7.2.1 Global Buspirone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Buspirone Revenue Market Share by Application (2021-2032)
- 7.3 Global Buspirone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Buspirone Value Chain Analysis
- 8.1.1 Buspirone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Buspirone Production Mode & Process
- 8.2 Buspirone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Buspirone Distributors
- 8.2.3 Buspirone Customers
9 Global Buspirone Analyzing Market Dynamics
- 9.1 Buspirone Industry Trends
- 9.2 Buspirone Industry Drivers
- 9.3 Buspirone Industry Opportunities and Challenges
- 9.4 Buspirone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst